Icure Pharmaceutical Incorporation

₩1,319As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:175250Consumer Staples
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR (24.99%)
Div yield —
ROE (58.78%)
Perfumes, Cosmetics, and Other Toilet Preparations
Beta (5Y) 0.33
PE TTM —
TSR TTM —
Mkt cap ₩49.29B
ROIC (21.46%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,445
9.53%
(79.90%)
Hold 7|1|5|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
17.06
18.87
20.83
20.83
13.38%
29.95%
33.03%
20.52%
Revenue₩B
4.736
4.619
4.540
4.771
13.37%
5.57%
3.61%
3.68%
Peers (US$36.34M)
Cap (US$)
PE
44.42M
8.795x
44.20M
—
Capital
TTM
5Y
10Y
Leveragex
3.558
0.218
0.181
EBIT/Intx
0.723
1.342
1.292
Own earn%
2.61
(242.77)
(201.52)
Sh yield%
56.46
41.47
41.66
Owners
Insiders/Inst%
6.90
64.00
Short interest%
4.36
SBC / revenue%
0.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
9–15
$1 testx
0.0
Incr. ROIC%
3